Target maintenance dose for peanut oral immunotherapy is 300 mg protein (or less): Pros and cons

Julia Upton; Arnon Elizur

doi:10.1111/all.16188

Target maintenance dose for peanut oral immunotherapy is 300 mg protein (or less): Pros and cons

Julia Upton^*, Arnon Elizur

^*Corresponding author for this work

Pediatrics

University of Toronto

Research output: Contribution to journal › Comment/debate

Original language	English
Pages (from-to)	2305-2306
Number of pages	2
Journal	Allergy: European Journal of Allergy and Clinical Immunology
Volume	79
Issue number	8
DOIs	https://doi.org/10.1111/all.16188
State	Published - Aug 2024

Access to Document

10.1111/all.16188

Cite this

@article{97ec727d43d741b5b0295afc22f999c1,

title = "Target maintenance dose for peanut oral immunotherapy is 300 mg protein (or less): Pros and cons",

author = "Julia Upton and Arnon Elizur",

year = "2024",

month = aug,

doi = "10.1111/all.16188",

language = "אנגלית",

volume = "79",

pages = "2305--2306",

journal = "Allergy: European Journal of Allergy and Clinical Immunology",

issn = "0105-4538",

publisher = "Wiley-Blackwell Publishing Ltd",

number = "8",

}

TY - JOUR

T1 - Target maintenance dose for peanut oral immunotherapy is 300 mg protein (or less)

T2 - Pros and cons

AU - Upton, Julia

AU - Elizur, Arnon

PY - 2024/8

Y1 - 2024/8

UR - http://www.scopus.com/inward/record.url?scp=85195373927&partnerID=8YFLogxK

U2 - 10.1111/all.16188

DO - 10.1111/all.16188

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.comment???

C2 - 38841823

AN - SCOPUS:85195373927

SN - 0105-4538

VL - 79

SP - 2305

EP - 2306

JO - Allergy: European Journal of Allergy and Clinical Immunology

JF - Allergy: European Journal of Allergy and Clinical Immunology

IS - 8

ER -

Target maintenance dose for peanut oral immunotherapy is 300 mg protein (or less): Pros and cons

Access to Document

Other files and links

Cite this